Biological Aging Linked to Increased Gout Risk, New Study Reveals
Table of Contents
A groundbreaking new analysis suggests biological aging—how quickly your body deteriorates—may be a critical, previously overlooked factor in the development of hyperuricemia, gout, and the potential for diet-driven prevention.
A large-scale prospective study involving 412,493 participants from the UK Biobank has revealed a significant connection between the rate of biological aging and the risk of developing gout. Researchers found that accelerated aging is associated with higher levels of serum uric acid and a substantially increased likelihood of both hyperuricemia and gout.
Accelerated Aging and Uric Acid Levels
The study, published in International Journal of Surgery in July 2025, utilized multiple regression models to assess the relationship between biological aging and uric acid levels. Investigators discovered that each step of accelerated biological aging corresponded to an average increase of 8.1 μmol/L in serum uric acid. This finding was supported by robust statistical data and narrow confidence intervals, indicating a strong and reliable correlation.
“These results demonstrate a clear link between the pace of biological aging and the concentration of uric acid in the blood,” one analyst noted.
Increased Odds of Hyperuricemia and Gout
Individuals experiencing accelerated biological aging faced a significantly higher risk of developing related conditions. Compared to their peers with delayed aging, those with accelerated aging exhibited a 40% increase in the odds of developing hyperuricemia—a condition characterized by high uric acid levels—and a 39% increase in the odds of being diagnosed with gout, a painful form of inflammatory arthritis.
Importantly, the study also found that accelerated aging worsened outcomes for those already living with hyperuricemia. Participants with existing hyperuricemia who also showed signs of accelerated aging had a further 14% increase in the odds of progressing to gout. This suggests that biological aging isn’t merely a background factor, but actively modifies the disease’s progression.
Genetic Evidence Supports Causal Link
To move beyond simple association, the researchers employed Mendelian randomization—a technique that uses genetic variations to infer causality. They found that genetically determined traits associated with delayed biological aging were linked to a lower risk of gout. This genetic evidence strengthens the argument for a causal pathway, suggesting that slowing biological aging can directly reduce gout risk, particularly in individuals with hyperuricemia.
Diet and Antioxidants Offer Potential Protective Effects
The study also explored the role of diet, specifically focusing on the composite dietary antioxidant index as a marker of an “anti-aging” dietary pattern. Among participants with hyperuricemia, those with a positive dietary antioxidant index—indicating a diet rich in antioxidants—demonstrated a marginally significant 68% reduction in the odds of developing gout compared to those with a negative index.
While the results were not definitively conclusive, researchers suggest that prioritizing antioxidant-rich foods may contribute to healthy aging and gout prevention in individuals with elevated uric acid levels. .
Implications for Gout Prevention and Clinical Practice
These findings have significant implications for how clinicians approach the prevention and management of hyperuricemia and gout. The study positions biological aging as a crucial risk dimension, alongside traditional metabolic factors.
“Assessing markers of biological aging may help stratify gout risk in patients with elevated uric acid,” a senior official stated. “This allows for a more personalized and proactive approach to prevention.”
The data also underscore the importance of healthy aging strategies, including dietary patterns rich in antioxidants, as a potential complement to traditional pharmacologic urate lowering therapies. By addressing biological aging alongside conventional treatments, healthcare providers may be able to more effectively prevent the progression from hyperuricemia to gout.
Reference: Li N et al. Biological aging and gout risk in hyperuricemia: a UK biobank cohort study. Int J Surg. 2025;doi:10.1097/JS9.0000000000003948.
